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The Ca2þ sensitivity of cardiac muscle force development can be adversely al-
tered during disease. Since troponin C (TnC) is the Ca2þ sensor for muscle con-
traction, TnC’s Ca2þ binding properties may be affected by the disease related
protein modifications. To test this hypothesis, a fluorescent TnC was utilized
to measure the Ca2þ binding sensitivity of TnC in the physiologically relevant
biochemical model system of reconstituted thin filaments. Consistent with the
pathophysiology, the inherited restrictive cardiomyopathy (RCM) mutation
TnI R192H and ischemia induced truncation of TnI (residues 1-192) increased
TnC’s Ca2þ binding sensitivity ~3 fold and ~7 fold, respectively; while the di-
lated cardiomyopathy (DCM) mutation TnT deltaK210 decreased TnC’s Ca2þ
binding sensitivity ~ 3 fold. Since the symptoms of the diseases may be caused
by the abnormal Ca2þ binding, correcting the Ca2þ binding might improve car-
diac function. To achieve this goal, we have engineered TnC constructs with
a wide, yet adjustable, range of Ca2þ binding sensitivities by modulating the neg-
atively charged residues in the Ca2þ chelating loop and/or by replacing key hy-
drophobic amino acids in the regulatory domain of TnC with polar Gln. We were
able to correct both the increased and decreased thin filament Ca2þ sensitivities
caused by the disease associated proteins via replacing the wild type TnC with
specifically engineered TnC constructs. Additionally, engineered TnC con-
structs can correct the disease related abnormal Ca2þ sensitivity of the acto-my-
osin ATPase assay and the force-pCa relationship in skinned trabeculae. This
study can potentially lead to a novel therapeutic strategy for treating cardiac
muscle diseases.
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Sarcomere Length Dependent Contractile Activation is Reduced in Rat
Trabeculae Exchanged with cTn Containing the L48Q cTnC Variant Inde-
pendently of Strong Binding Cross-Bridges
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Calcium sensitivity of the force-pCa relationship depends strongly on sarco-
mere length (SL) in cardiac muscle. It can also be influenced by maneuvers
that alter the distribution of cross-bridges within the cross-bridge cycle. We
have demonstrated that cardiac trabeculae have left-shifted and virtually elim-
inated SL dependence of force-pCa relationship following passive exchange
with cTn containing a mutant (L48Q) cTnC (with enhanced TnC-TnI interac-
tion). Here we designed experiments to investigate the importance of strongly
bound crossbridges and lattice spacing in modulating the force-pCa relation-
ship of WT and L48Q cTnC-cTn exchanged trabeculae. Using 3% dextran at
SL ¼ 2.0 mm to osmotically compress preparations to widths ~SL ¼ 2.3 mm,
we observed increased maximal force but not increased pCa50 in L48Q
cTnC-cTn exchanged trabeculae. Conversely, crossbridge inhibition with of
2,3-butanedione monoxime (BDM, 7 mM) at SL 2.3 mm decreased maximal
force and Ca2þ sensitivity in native and WT-cTn exchanged trabeculae to
levels measured at ~SL ¼ 2.0 mm. L48QcTnC-cTn exchanged preparations
treated with BDM also decreased maximal force to that seen at SL ¼ 2.0 mm,
but demonstrated no shift in Ca2þ sensitivity. This result is similar to decrease
in maximal force but no shift in Ca2þ sensitivity for L48Q cTnC-cTn ex-
changed preparations at SL 2.0 vs. 2.3 mm. The combined results further sup-
port the idea that L48Q cTnC confers crossbridge independence on thin fila-
ment activation. It may also imply that native thin filaments are dependent
on strong crossbridge binding for full activation because of relatively weak
cTnC-cTnI interaction. Finally, the relative strength of cTnC-cTnI interaction
may be an important determinant in length dependent activation of cardiac
muscle. Support provided by NIH HL65497 (MR) and T32 HL07828 (FSK).
1843-Pos
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Gene based therapies targeting cardiac myofilaments offer a novel way to halt
or even reverse cardiac dysfunction following infarction by enhancing contrac-
tility of the heart. Experiments here were designed to test the ability of an en-
gineered troponin C (L48Q), with increased Ca2þ binding affinity to abrogate
contractile deficits of isolated adult rat cardiomyocytes from rat hearts infarctedby permanent ligation of the left descending coronary artery. After 4 weeks car-
diomyocytes from these and sham-operated, non-infarcted hearts were cultured
and incubated with adenoviral constructs containing cDNA for either GFP þ
WT cTnC or GFPþ L48Q cTnC. After 48-72 hours, stimulated cardiomyocyte
contraction and relaxation were measured using video microscopy (IonOptix).
In a sub-set of cardiomyocytes intracellular Ca2þ transients were measured fol-
lowing incubation with Fura-2. Myocardial infarction resulted in decreased ex-
tent (8.6 þ/- 1.0 %) and velocity of shortening (93.4 þ/- 13.0 mm/s) and relax-
ation velocity (51.3þ/- 6.4 mm/s), compared to control myocytes (12.1þ/- 2.4 %
and 147.3 þ/- 16.7 mm/s and 118.8 þ/- 16.3 mm/s, respectively). Expression of
L48Q cTnC in cardiomyocytes from infarcted hearts increased fractional short-
ening, shortening velocity, and relaxation velocity to near control values of
10.9 þ/- 1.3 % and 165.0 þ/- 23.6 mm/s and 141.7 þ/- 32.2 mm/s, respectively.
Interestingly, the peak Ca2þ transient amplitude was increased in cardiomyo-
cytes from infarcted hearts, from 9.9 þ/- 0.5 % in control cells to 23.0 þ/-
2.69 % in cells from infarcted hearts, which was also restored to near control
values with L48Q cTnC transfection to 11.9 þ/- 0.8 %. These results suggest
that targeted expression of L48Q cTnC may improve myocardial function in
infarcted hearts by reversing contractile dysfunction and improving sensitivity
to intracellular Ca2þ. Funding provided by NIH_HL091368 (MR, CEM),
AHA_T32 HL07828 (FSK).
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Transgenic models with mutants of cardiac troponin I, cTnI-PKA S22,23D
(cTnIDD22,23) or cTnI-PKC S22A,S23D,S42,S44D (cTnI PKA/PKC) dis-
played differential force-frequency relationships (FFR) in vivo. We hypothe-
sized that these cTnI phospho-mimics would impact cardiac muscle force de-
velopment and Ca2þ sensitivity in opposite directions in a rate dependent
fashion. Our study shows that cTnIDD22,23 increases (while cTnI PKA/PKC de-
creases) its ability to generate normal force per unit of [Ca2þ]i when stimula-
tion frequency increases. Force-[Ca2þ]I hysteresis-loops revealed that
cTnIDD22,23 shows an increased calcium sensitivity in the activation phase
of force-[Ca2þ]i loops at 1 to 4 Hz when compared to NTG (Figure1E). An in-
tegrated computational model that encompasses electrophysiology, Ca2þ dy-
namics, contractile and mitochondrial activity (ECME model) indicates that
these cTnI mutants might change
the association-dissociation constants
for Ca2þ binding, both the low- and/
or high-affinity binding sites, of tro-
ponin complex. Our data indicate
that cTnI phosphorylation at PKA
sites is a crucial mediator of the
FFR by increasing the frequency-de-
pendent myofilament sensitivity;
which might be achieved by adaptive
changes on association-dissociation
constants for Ca2þ binding of the tro-
ponin complex.1845-Pos
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Proteolytic degradation of Troponin I (cTnI) may be the cause for the depressed
contractility that is seen in myocardial stunning. Here, we studied the impact of
a proteolytic fragment cTnI63-193 (identified by McDonough et al, 1999) on
cross-bridge cycling dynamics in isolated myocardium. Murine cTnI63-193 mu-
tant, as well as wild type cTnC and cTnT, were expressed in E.coli. Next, FPLC
purified Troponin (cTn) complex containing either wild type cTnI or cTnI63-193
was exchanged for endogenous cTn in skinned rat cardiac trabeculae; Western
blot analysis confirmed that >75% cTn was exchanged. Myofilament chemo-
mechanical cross-bridge dynamics were determined as function of [Ca2þ] at
SL=2.2 mm using an enzyme-coupled UV absorbance technique (de Tombe
& Stienen, 1995).Compared to wild-type exchange, cTnI63-193 exchanged fi-
bers displayed ~30% decrease in myofilament Ca2þ sensitivity (EC50). In con-
trast, neither maximal tension development, nor maximal ATPase activity (and
consequently tension-cost), were significant different between the groups, nor
was cooperative thin filament activation (Hill coefficient). We conclude that
